Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside
Mucositis is one of the most common debilitating side effects related to chemotherapy (CT), radiation therapy (RT), targeted agents and immunotherapy. It is a complex process potentially involving any portion of the gastrointestinal tract and injuring the mucosa, leading to inflammatory or ulcerativ...
Main Authors: | Debora Basile, Paola Di Nardo, Carla Corvaja, Silvio Ken Garattini, Giacomo Pelizzari, Camilla Lisanti, Lucia Bortot, Lucia Da Ros, Michele Bartoletti, Matteo Borghi, Lorenzo Gerratana, Davide Lombardi, Fabio Puglisi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/6/857 |
Similar Items
-
New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury
by: Marika Cinausero, et al.
Published: (2017-06-01) -
Vaccine Strategies to Elicit Mucosal Immunity
by: Yufeng Song, et al.
Published: (2024-02-01) -
Editorial: Mucosal vaccines for the induction of antimicrobial immunoglobulin A
by: Reiko Shinkura
Published: (2024-02-01) -
The Mucoadhesive Nanoparticle-Based Delivery System in the Development of Mucosal Vaccines
by: Zhao K, et al.
Published: (2022-09-01) -
Incidence, severity and management of cancer chemotherapy related oral mucositis in Eastern Cape and Western Cape
by: Johanna E. Maree, et al.
Published: (2012-10-01)